Clinical course of preterm prelabor rupture of membranes in the era of prophylactic antibiotics

BMC Research Notes

Lalita Kulmala¹  Vorapong Phupong¹ 

[1]Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University, Rama IV Road, Pathumwan, Bangkok 10330, Thailand

关键词: Corticosteroids;    Prophylactic antibiotic;    Latency;    Prelabor rupture of membranes;    Preterm;   

Others  :  1165643
DOI  :  10.1186/1756-0500-5-515

 received in 2012-02-07, accepted in 2012-09-17,  发布年份 2012

【 摘 要 】

Background

Preterm prelabor rupture of membrane (PPROM) causes maternal and neonatal complications. Prophylactic antiobiotics were used in the management of PPROM. The objectives of this retrospective study were to compare clinical course and outcome of PPROM managed expectantly with prophylactic antibiotics and antenatal corticosteroids with those without prophylactic antibiotics and antenatal corticosteroids.

Results

A total of 170 cases of singleton pregnant women with gestational age between 28–34 weeks suffering from PROM during January 1998 to December 2009 were included; 119 cases received prophylactic antibiotics and antenatal corticosteroids while 51 cases did not received prophylactic antibiotics and antenatal corticosteroids. Median latency period in the study group was significantly longer than in the control group (89.8 vs. 24.3 hours, P < 0.001). The percentage of patients who did not deliver within 48 hours and within 7 days in the study group were also significantly higher than in control group (64.7 vs. 31.4%, P < 0.001 and 29.4 vs. 7.8%, P = 0.002, respectively). Maternal infectious morbidity was comparable between groups (17.6% vs. 13.7%, P = 0.52). Neonatal infectious morbidity was significantly lesser in study group than control group (21% vs. 35.3%, p = 0.04).

Conclusions

Latency period of PPROM after using prophylactic antibiotics and antenatal corticosteroids increased while neonatal infectious morbidity was low. But maternal infectious morbidity was not increased. This retrospective study confirms the benefit of prophylactic antibiotics and antenatal corticosteroids in management of PPROM.

【 授权许可】

   
2012 Phupong and Kulmala; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Phupong V, Taneepanichskul S: Prelabour rupture of membranes. J Paediatr Obstet Gynaecol 2003, 29:25-32.
• [2]Phupong V, Taneepanichskul S: Outcome of preterm premature rupture of membranes. J Med Assoc Thai 2000, 83(6):640-645.
• [3]Phupong V: Clinical course of preterm premature rupture of membranes. Chula Med J 2000, 44(11):859-866.
• [4]Nelson LH, Anderson RL, O’Shea TM, Swain M: Expectant management of preterm premature rupture of the membranes. Am J Obstet Gynecol 1994, 171(2):350-356. discussion 356–358
• [5]Mercer BM, Crocker LG, Boe NM, Sibai BM: Induction versus expectant management in premature rupture of the membranes with mature amniotic fluid at 32 to 36 weeks: a randomized trial. Am J Obstet Gynecol 1993, 169(4):775-782.
• [6]Graham RL, Gilstrap LC 3rd, Hauth JC, Kodack-Garza S, Conaster DG: Conservative management of patients with premature rupture of fetal membranes. Obstet Gynecol 1982, 59(5):607-610.
• [7]Cox SM, Williams ML, Leveno KJ: The natural history of preterm ruptured membranes: what to expect of expectant management. Obstet Gynecol 1988, 71(4):558-562.
• [8]Kenyon SL, Taylor DJ, Tarnow-Mordi W: Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. ORACLE Collaborative Group. Lancet 2001, 357(9261):979-988.
• [9]Mercer BM, Miodovnik M, Thurnau GR, Goldenberg RL, Das AF, Ramsey RD, Rabello YA, Meis PJ, Moawad AH, Iams JD, et al.: Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. JAMA 1997, 278(12):989-995.
• [10]ACOG Practice Bulletin No. 80: premature rupture of membranes. Clinical management guidelines for obstetrician-gynecologists. Obstet Gynecol 2007, 109(4):1007-1019.
• [11]ACOG practice bulletin: Premature rupture of membranes. Clinical management guidelines for obstetrician-gynecologists. Number 1, June 1998. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 1998, 63(1):75-84.
• [12]Fraser N, Davies BW, Cusack J: Neonatal omphalitis: a review of its serious complications. Acta Paediatr 2006, 95(5):519-522.
• [13]Magwali TL, Chipato T, Majoko F, Rusakaniko S, Mujaji C: Prophylactic augmentin in prelabor preterm rupture of the membranes. Int J Gynaecol Obstet 1999, 65(3):261-265.
• [14]Ryo E, Ikeya M, Sugimoto M: Clinical study of the effectiveness of imipenem/cilastatin sodium as the antibiotics of first choice in the expectant management of patients with preterm premature rupture of membranes. J Infect Chemother 2005, 11(1):32-36.
• [15]August Fuhr N, Becker C, van Baalen A, Bauer K, Hopp H: Antibiotic therapy for preterm premature rupture of membranes - results of a multicenter study. J Perinat Med 2006, 34(3):203-206.
• [16]Mercer BM, Moretti ML, Prevost RR, Sibai BM: Erythromycin therapy in preterm premature rupture of the membranes: a prospective, randomized trial of 220 patients. Am J Obstet Gynecol 1992, 166(3):794-802.
• [17]Broekhuizen FF, Gilman M, Hamilton PR: Amniocentesis for gram stain and culture in preterm premature rupture of the membranes. Obstet Gynecol 1985, 66(3):316-321.